5 November 2013 - Deborah Wilkes
Archived
Teva Pharmaceutical Industries will continue to build its OTC business following the sudden departure of its president and chief executive officer Dr Jeremy Levin.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.